Literature DB >> 17348096

Escitalopram oxalate: co-existence of oxalate dianions and oxalic acid molecules in the same crystal.

William T A Harrison1, H S Yathirajan, S Bindya, H G Anilkumar.   

Abstract

Entities:  

Year:  2007        PMID： 17348096     DOI： 10.1107/s010827010605520x

Source DB:  PubMed          Journal:  Acta Crystallogr C        ISSN： 0108-2701            Impact factor:   1.172


× No keyword cloud information.
  6 in total

Review 1.  Continuous manufacturing of co-crystals: challenges and prospects.

Authors:  Rahul B Chavan; Rajesh Thipparaboina; Balvant Yadav; Nalini R Shastri
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

2.  Enrofloxacinium oxalate.

Authors:  Thammarse S Yamuna; Manpreet Kaur; Brian J Anderson; Jerry P Jasinski; H S Yathirajan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-01-25

3.  Crystal Engineering of Ionic Cocrystals Sustained by the Phenol-Phenolate Supramolecular Heterosynthon.

Authors:  Shasha Jin; Rana Sanii; Bai-Qiao Song; Michael J Zaworotko
Journal:  Cryst Growth Des       Date:  2022-06-21       Impact factor: 4.010

Review 4.  Drug-drug cocrystals: Opportunities and challenges.

Authors:  Xiaojuan Wang; Shuzhang Du; Rui Zhang; Xuedong Jia; Ting Yang; Xiaojian Zhang
Journal:  Asian J Pharm Sci       Date:  2020-07-09       Impact factor: 6.598

Review 5.  Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs.

Authors:  Anna Karagianni; Maria Malamatari; Kyriakos Kachrimanis
Journal:  Pharmaceutics       Date:  2018-01-25       Impact factor: 6.321

Review 6.  A Review about Regulatory Status and Recent Patents of Pharmaceutical Co-Crystals.

Authors:  Arun Kumar; Sandeep Kumar; Arun Nanda
Journal:  Adv Pharm Bull       Date:  2018-08-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.